Project
Illumina Body Map 2 (GSE30611)
Navigation
Downloads
Results for IRF2_STAT2_IRF8_IRF1
Z-value: 4.47
Motif logo
Transcription factors associated with IRF2_STAT2_IRF8_IRF1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
IRF2
|
ENSG00000168310.11 | interferon regulatory factor 2 |
|
STAT2
|
ENSG00000170581.14 | signal transducer and activator of transcription 2 |
|
IRF8
|
ENSG00000140968.11 | interferon regulatory factor 8 |
|
IRF1
|
ENSG00000125347.15 | interferon regulatory factor 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| IRF8 | hg38_v1_chr16_+_85902689_85902838 | 0.83 | 4.9e-09 | Click! |
| IRF1 | hg38_v1_chr5_-_132490750_132490840 | 0.81 | 2.5e-08 | Click! |
| IRF2 | hg38_v1_chr4_-_184474518_184474556 | 0.78 | 1.1e-07 | Click! |
| STAT2 | hg38_v1_chr12_-_56360084_56360146 | 0.55 | 1.2e-03 | Click! |
Activity profile of IRF2_STAT2_IRF8_IRF1 motif
Sorted Z-values of IRF2_STAT2_IRF8_IRF1 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of IRF2_STAT2_IRF8_IRF1
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 10.5 | 31.6 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 8.7 | 17.4 | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) |
| 8.1 | 121.7 | GO:0018377 | protein myristoylation(GO:0018377) |
| 7.3 | 29.3 | GO:0050822 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 6.9 | 20.7 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 5.5 | 22.2 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 5.1 | 40.7 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
| 5.0 | 15.1 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 4.9 | 14.8 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 4.6 | 18.4 | GO:1902524 | positive regulation of protein K48-linked ubiquitination(GO:1902524) |
| 4.5 | 13.4 | GO:0034769 | basement membrane disassembly(GO:0034769) |
| 4.1 | 12.4 | GO:1904887 | regulation of thioredoxin peroxidase activity(GO:1903123) negative regulation of thioredoxin peroxidase activity(GO:1903124) negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation(GO:1903125) Wnt signalosome assembly(GO:1904887) negative regulation of peroxidase activity(GO:2000469) |
| 4.1 | 12.3 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 4.0 | 24.2 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 4.0 | 15.8 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 3.9 | 19.4 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
| 3.8 | 49.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 3.7 | 15.0 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
| 3.7 | 11.2 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
| 3.6 | 3.6 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 3.4 | 17.2 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 3.4 | 10.2 | GO:2000547 | mesangial cell-matrix adhesion(GO:0035759) regulation of dendritic cell dendrite assembly(GO:2000547) |
| 3.3 | 10.0 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 3.1 | 18.7 | GO:0006154 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
| 3.0 | 21.2 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 2.8 | 14.2 | GO:0052056 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
| 2.8 | 14.1 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
| 2.8 | 8.4 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
| 2.7 | 21.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 2.7 | 37.4 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
| 2.4 | 14.3 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 2.4 | 9.4 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
| 2.4 | 11.8 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 2.3 | 11.6 | GO:2000538 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 2.3 | 13.8 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 2.3 | 6.8 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
| 2.2 | 2.2 | GO:0002859 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
| 2.2 | 28.5 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 2.2 | 17.2 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
| 2.1 | 10.6 | GO:1901545 | cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
| 2.1 | 10.5 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
| 2.1 | 6.2 | GO:1904604 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
| 2.0 | 8.0 | GO:0010607 | negative regulation of cytoplasmic mRNA processing body assembly(GO:0010607) |
| 1.9 | 16.9 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
| 1.8 | 16.6 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 1.8 | 21.8 | GO:0030578 | PML body organization(GO:0030578) |
| 1.7 | 59.3 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
| 1.7 | 78.9 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 1.7 | 15.3 | GO:0035696 | monocyte extravasation(GO:0035696) |
| 1.6 | 17.5 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 1.6 | 15.8 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 1.6 | 4.7 | GO:0072308 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
| 1.5 | 6.0 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 1.5 | 22.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 1.5 | 1.5 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
| 1.4 | 7.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 1.4 | 6.8 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 1.3 | 12.1 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 1.3 | 4.0 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) macrophage migration inhibitory factor signaling pathway(GO:0035691) |
| 1.3 | 31.9 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 1.3 | 14.5 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
| 1.3 | 7.7 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
| 1.2 | 28.0 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 1.2 | 10.9 | GO:0045345 | positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 1.2 | 8.3 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 1.2 | 5.9 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 1.2 | 8.1 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 1.2 | 4.6 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 1.1 | 4.5 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
| 1.1 | 12.4 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 1.1 | 3.3 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 1.1 | 3.3 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 1.1 | 5.4 | GO:0009197 | dUDP biosynthetic process(GO:0006227) dTDP biosynthetic process(GO:0006233) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dTDP metabolic process(GO:0046072) dUDP metabolic process(GO:0046077) |
| 1.1 | 22.5 | GO:0003373 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.9 | 7.6 | GO:0089700 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) protein kinase D signaling(GO:0089700) |
| 0.9 | 2.8 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.9 | 5.6 | GO:1902164 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) platelet alpha granule organization(GO:0070889) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.9 | 2.8 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.9 | 9.8 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.9 | 2.7 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.8 | 2.5 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
| 0.8 | 1.7 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.8 | 9.1 | GO:0042100 | B cell proliferation(GO:0042100) |
| 0.8 | 6.6 | GO:0035655 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.8 | 54.8 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.8 | 4.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.8 | 7.3 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.8 | 17.8 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.8 | 3.2 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 0.8 | 3.1 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.8 | 3.0 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 0.7 | 6.0 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.7 | 4.4 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 0.7 | 2.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.7 | 5.8 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.7 | 4.3 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) |
| 0.7 | 85.2 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.7 | 10.3 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
| 0.7 | 4.8 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.7 | 4.7 | GO:0048014 | Tie signaling pathway(GO:0048014) |
| 0.6 | 3.9 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.6 | 13.5 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.6 | 18.0 | GO:1900115 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.6 | 14.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 0.6 | 17.0 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
| 0.6 | 3.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.6 | 3.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.6 | 1.2 | GO:0031296 | B cell costimulation(GO:0031296) |
| 0.6 | 16.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.6 | 3.0 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) thymocyte migration(GO:0072679) |
| 0.6 | 12.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.6 | 2.8 | GO:0070269 | pyroptosis(GO:0070269) |
| 0.6 | 1.7 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.6 | 9.4 | GO:0046449 | creatinine metabolic process(GO:0046449) |
| 0.6 | 5.0 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
| 0.5 | 1.6 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
| 0.5 | 4.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.5 | 2.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.5 | 1.4 | GO:1902263 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 0.5 | 1.9 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.5 | 3.3 | GO:0030421 | defecation(GO:0030421) |
| 0.5 | 2.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.5 | 1.9 | GO:0033037 | polysaccharide localization(GO:0033037) |
| 0.5 | 2.3 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.5 | 3.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.5 | 3.6 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.4 | 1.8 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
| 0.4 | 1.8 | GO:2000753 | regulation of phospholipid scramblase activity(GO:1900161) positive regulation of phospholipid scramblase activity(GO:1900163) regulation of glucosylceramide catabolic process(GO:2000752) positive regulation of glucosylceramide catabolic process(GO:2000753) regulation of sphingomyelin catabolic process(GO:2000754) positive regulation of sphingomyelin catabolic process(GO:2000755) |
| 0.4 | 8.4 | GO:0060022 | hard palate development(GO:0060022) |
| 0.4 | 1.3 | GO:0097272 | ammonia homeostasis(GO:0097272) |
| 0.4 | 5.7 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.4 | 2.6 | GO:0019075 | virus maturation(GO:0019075) |
| 0.4 | 1.7 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.4 | 2.5 | GO:0008582 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.4 | 23.1 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.4 | 1.2 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
| 0.4 | 6.4 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.4 | 4.8 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.4 | 2.8 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.4 | 1.2 | GO:0098583 | mastication(GO:0071626) learned vocalization behavior(GO:0098583) |
| 0.4 | 1.2 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.4 | 25.8 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
| 0.4 | 0.7 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
| 0.4 | 30.7 | GO:0070206 | protein trimerization(GO:0070206) |
| 0.4 | 1.1 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.4 | 1.4 | GO:0045208 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.4 | 0.4 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
| 0.3 | 2.0 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
| 0.3 | 7.1 | GO:0035456 | response to interferon-beta(GO:0035456) |
| 0.3 | 22.7 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
| 0.3 | 4.2 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.3 | 7.1 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.3 | 1.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
| 0.3 | 1.9 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.3 | 3.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.3 | 1.0 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.3 | 1.5 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.3 | 0.3 | GO:0034759 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
| 0.3 | 5.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.3 | 1.2 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.3 | 5.8 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
| 0.3 | 2.0 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
| 0.3 | 6.4 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.3 | 9.6 | GO:0045332 | phospholipid translocation(GO:0045332) |
| 0.3 | 4.7 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.3 | 7.4 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.3 | 8.4 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.3 | 1.6 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.3 | 1.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.3 | 2.4 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
| 0.3 | 0.8 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
| 0.3 | 1.3 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 0.3 | 3.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.3 | 3.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.3 | 1.5 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.2 | 0.5 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
| 0.2 | 1.7 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.2 | 2.2 | GO:0002353 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
| 0.2 | 2.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.2 | 4.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.2 | 2.4 | GO:0070842 | aggresome assembly(GO:0070842) |
| 0.2 | 5.9 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.2 | 0.7 | GO:0015734 | taurine transport(GO:0015734) |
| 0.2 | 4.4 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.2 | 1.4 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
| 0.2 | 2.2 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.2 | 1.5 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.2 | 0.7 | GO:0060981 | cell migration involved in coronary angiogenesis(GO:0060981) |
| 0.2 | 1.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.2 | 0.9 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.2 | 0.7 | GO:0031247 | actin rod assembly(GO:0031247) |
| 0.2 | 1.5 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.2 | 0.9 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.2 | 1.3 | GO:1904799 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.2 | 6.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.2 | 4.7 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
| 0.2 | 2.0 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.2 | 8.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.2 | 2.0 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.2 | 7.4 | GO:0032479 | regulation of type I interferon production(GO:0032479) |
| 0.2 | 0.2 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.2 | 1.6 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.2 | 1.2 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
| 0.2 | 0.8 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
| 0.2 | 10.0 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.2 | 1.7 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 | 1.0 | GO:0061741 | vacuolar transmembrane transport(GO:0034486) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 0.2 | 0.8 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.2 | 3.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.2 | 2.4 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.2 | 6.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.2 | 1.5 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.2 | 0.7 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 0.2 | 2.7 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.2 | 0.2 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
| 0.2 | 1.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.2 | 20.6 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
| 0.2 | 1.6 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.2 | 0.7 | GO:0042335 | cuticle development(GO:0042335) |
| 0.2 | 1.7 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.2 | 1.2 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
| 0.2 | 10.7 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
| 0.2 | 3.0 | GO:0061470 | interleukin-21 production(GO:0032625) macrophage colony-stimulating factor production(GO:0036301) T follicular helper cell differentiation(GO:0061470) interleukin-21 secretion(GO:0072619) regulation of macrophage colony-stimulating factor production(GO:1901256) |
| 0.2 | 0.7 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.2 | 2.0 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.2 | 5.5 | GO:0003094 | glomerular filtration(GO:0003094) |
| 0.2 | 3.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.2 | 0.9 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
| 0.2 | 6.7 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.2 | 5.2 | GO:0045109 | intermediate filament organization(GO:0045109) |
| 0.2 | 3.5 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
| 0.2 | 3.0 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.2 | 0.8 | GO:1904075 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
| 0.2 | 0.5 | GO:0009720 | detection of hormone stimulus(GO:0009720) |
| 0.1 | 0.9 | GO:0032916 | positive regulation of transforming growth factor beta3 production(GO:0032916) chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 0.1 | 2.0 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.1 | 13.0 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.1 | 1.1 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.1 | 9.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 | 4.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.1 | 2.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 | 0.5 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.1 | 0.3 | GO:0070340 | toll-like receptor 1 signaling pathway(GO:0034130) regulation of toll-like receptor 2 signaling pathway(GO:0034135) positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) detection of bacterial lipoprotein(GO:0042494) detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
| 0.1 | 5.9 | GO:0010390 | histone monoubiquitination(GO:0010390) |
| 0.1 | 0.7 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.1 | 0.3 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.1 | 0.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.1 | 25.0 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
| 0.1 | 0.4 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.1 | 2.1 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.1 | 1.8 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.1 | 1.8 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
| 0.1 | 0.5 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
| 0.1 | 1.3 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.1 | 0.3 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.1 | 2.9 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.1 | 8.8 | GO:0002456 | T cell mediated immunity(GO:0002456) |
| 0.1 | 0.7 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.1 | 0.3 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.1 | 1.8 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.1 | 7.3 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 | 0.3 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
| 0.1 | 4.8 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 | 0.7 | GO:0061743 | motor learning(GO:0061743) |
| 0.1 | 0.3 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 0.1 | 4.8 | GO:0019835 | cytolysis(GO:0019835) |
| 0.1 | 0.4 | GO:0030576 | Cajal body organization(GO:0030576) |
| 0.1 | 1.1 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 | 3.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 | 0.8 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.1 | 2.9 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 | 5.9 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.1 | 0.8 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 | 1.4 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
| 0.1 | 1.8 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.1 | 0.6 | GO:0021764 | amygdala development(GO:0021764) |
| 0.1 | 2.9 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.1 | 3.2 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
| 0.1 | 8.2 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
| 0.1 | 0.5 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.1 | 1.1 | GO:0048664 | neuron fate determination(GO:0048664) |
| 0.1 | 1.7 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.1 | 1.4 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.1 | 0.4 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.1 | 0.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 | 2.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.1 | 0.3 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.1 | 17.0 | GO:0015992 | proton transport(GO:0015992) |
| 0.1 | 0.6 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.1 | 1.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.1 | 1.0 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 | 0.3 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 0.1 | 0.9 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.1 | 0.9 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
| 0.1 | 0.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 | 2.3 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.1 | 5.8 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
| 0.1 | 4.2 | GO:0045576 | mast cell activation(GO:0045576) |
| 0.1 | 1.8 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
| 0.1 | 0.8 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.1 | 0.7 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 0.1 | 1.8 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
| 0.1 | 15.9 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.1 | 3.6 | GO:0031529 | ruffle organization(GO:0031529) |
| 0.1 | 1.4 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 | 2.0 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.1 | 0.5 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
| 0.1 | 44.2 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
| 0.1 | 0.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 0.1 | 0.6 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.1 | 0.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.1 | 0.7 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.1 | 0.9 | GO:0015867 | ADP transport(GO:0015866) ATP transport(GO:0015867) |
| 0.1 | 3.2 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 | 0.7 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 | 0.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 | 0.5 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.1 | 1.5 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
| 0.1 | 0.2 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.1 | 0.3 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
| 0.1 | 8.5 | GO:0090630 | activation of GTPase activity(GO:0090630) |
| 0.1 | 0.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.1 | 0.3 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.1 | 0.3 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.1 | 2.6 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
| 0.1 | 4.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.1 | 0.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 | 2.2 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.1 | 0.4 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.1 | 1.8 | GO:0051923 | sulfation(GO:0051923) |
| 0.1 | 0.5 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
| 0.1 | 0.4 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 | 1.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 | 0.4 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
| 0.1 | 1.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
| 0.1 | 0.6 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
| 0.0 | 0.2 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
| 0.0 | 1.4 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.0 | 0.4 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.0 | 1.3 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.0 | 0.5 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
| 0.0 | 0.6 | GO:0072520 | seminiferous tubule development(GO:0072520) |
| 0.0 | 0.1 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.0 | 0.7 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.0 | 0.9 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.0 | 2.7 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.0 | 0.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.0 | 0.2 | GO:0072047 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) |
| 0.0 | 0.5 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 | 0.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.0 | 5.7 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.0 | 0.3 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.0 | 0.7 | GO:0038129 | ERBB3 signaling pathway(GO:0038129) |
| 0.0 | 0.5 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 0.0 | 3.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.0 | 0.5 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
| 0.0 | 1.6 | GO:0051972 | regulation of telomerase activity(GO:0051972) |
| 0.0 | 0.9 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.0 | 6.9 | GO:0009615 | response to virus(GO:0009615) |
| 0.0 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
| 0.0 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.0 | 1.0 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.0 | 0.6 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.0 | 1.6 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.0 | 0.3 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.0 | 0.1 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.0 | 1.1 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 | 0.8 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.0 | 0.6 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.0 | 0.1 | GO:0010877 | lipid transport involved in lipid storage(GO:0010877) |
| 0.0 | 0.4 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.0 | 1.2 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.0 | 0.5 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
| 0.0 | 0.8 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.0 | 0.3 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.0 | 0.4 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.0 | 0.1 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.0 | 0.7 | GO:0042102 | positive regulation of T cell proliferation(GO:0042102) |
| 0.0 | 0.1 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
| 0.0 | 0.7 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.0 | 0.4 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.0 | 0.5 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.0 | 0.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 | 0.3 | GO:0009651 | response to salt stress(GO:0009651) |
| 0.0 | 0.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.0 | 0.2 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.0 | 2.8 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.0 | 0.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.0 | 0.1 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.0 | 1.4 | GO:0001895 | retina homeostasis(GO:0001895) |
| 0.0 | 1.3 | GO:0006334 | nucleosome assembly(GO:0006334) |
| 0.0 | 0.7 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.0 | 0.3 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.0 | 0.5 | GO:0030641 | regulation of cellular pH(GO:0030641) |
| 0.0 | 0.8 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.0 | 0.0 | GO:1902173 | negative regulation of keratinocyte apoptotic process(GO:1902173) |
| 0.0 | 0.0 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
| 0.0 | 0.6 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.0 | 0.8 | GO:0006402 | mRNA catabolic process(GO:0006402) |
| 0.0 | 2.3 | GO:0006310 | DNA recombination(GO:0006310) |
| 0.0 | 1.5 | GO:0070268 | cornification(GO:0070268) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 8.7 | 60.8 | GO:0042825 | TAP complex(GO:0042825) |
| 7.3 | 58.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 7.1 | 28.5 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 6.5 | 38.9 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
| 4.1 | 12.4 | GO:0032473 | cytoplasmic side of mitochondrial outer membrane(GO:0032473) caveola neck(GO:0099400) |
| 3.5 | 17.4 | GO:0031905 | early endosome lumen(GO:0031905) |
| 2.8 | 16.7 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
| 2.6 | 28.5 | GO:0032010 | phagolysosome(GO:0032010) |
| 2.3 | 7.0 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
| 2.3 | 18.0 | GO:0043196 | varicosity(GO:0043196) |
| 1.7 | 20.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 1.6 | 8.1 | GO:0071754 | IgM immunoglobulin complex(GO:0071753) IgM immunoglobulin complex, circulating(GO:0071754) pentameric IgM immunoglobulin complex(GO:0071756) |
| 1.6 | 6.4 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 1.5 | 38.3 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
| 1.2 | 8.6 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 1.2 | 5.9 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 1.0 | 5.8 | GO:0036398 | TCR signalosome(GO:0036398) |
| 0.9 | 7.2 | GO:0005901 | caveola(GO:0005901) |
| 0.8 | 5.7 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.8 | 10.0 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.7 | 5.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.7 | 12.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.7 | 2.0 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 0.6 | 11.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.6 | 5.8 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.6 | 6.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.6 | 0.6 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.6 | 13.1 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.6 | 7.2 | GO:0032009 | early phagosome(GO:0032009) |
| 0.5 | 2.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.5 | 4.0 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
| 0.5 | 1.5 | GO:0016590 | ACF complex(GO:0016590) |
| 0.5 | 42.1 | GO:0015030 | Cajal body(GO:0015030) |
| 0.4 | 10.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.4 | 4.9 | GO:0016589 | NURF complex(GO:0016589) |
| 0.4 | 2.0 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
| 0.4 | 3.2 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.4 | 3.6 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.4 | 64.7 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.4 | 3.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.4 | 7.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.3 | 12.5 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.3 | 36.0 | GO:0005811 | lipid particle(GO:0005811) |
| 0.3 | 2.9 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.3 | 53.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.3 | 4.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.2 | 3.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.2 | 7.8 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.2 | 4.0 | GO:0071556 | integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
| 0.2 | 8.8 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.2 | 1.8 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.2 | 2.4 | GO:0016235 | aggresome(GO:0016235) |
| 0.2 | 9.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.2 | 3.5 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.2 | 88.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.2 | 1.2 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.2 | 2.2 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.2 | 0.6 | GO:0071547 | piP-body(GO:0071547) |
| 0.2 | 1.0 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 0.2 | 2.7 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.2 | 1.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.2 | 2.4 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.2 | 25.1 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.2 | 0.6 | GO:0033167 | ARC complex(GO:0033167) |
| 0.2 | 1.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.2 | 12.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.2 | 2.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.1 | 2.0 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
| 0.1 | 0.9 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.1 | 2.5 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.1 | 0.5 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.1 | 4.4 | GO:0018995 | host(GO:0018995) host cell(GO:0043657) |
| 0.1 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.1 | 2.0 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.1 | 0.5 | GO:0044307 | dendritic branch(GO:0044307) |
| 0.1 | 0.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.1 | 6.6 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.1 | 0.7 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.1 | 1.1 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.1 | 1.0 | GO:0005767 | secondary lysosome(GO:0005767) |
| 0.1 | 1.3 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.1 | 0.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.1 | 3.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.1 | 1.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.1 | 0.9 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 0.1 | 9.6 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.1 | 0.3 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 0.1 | 13.1 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.1 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.1 | 123.9 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
| 0.1 | 6.8 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.1 | 1.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.1 | 4.0 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.1 | 11.6 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
| 0.1 | 1.3 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.1 | 8.2 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.1 | 0.8 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.1 | 2.2 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.1 | 46.8 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.1 | 0.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.1 | 11.9 | GO:0005903 | brush border(GO:0005903) |
| 0.1 | 0.6 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.1 | 0.5 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.1 | 0.9 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 0.1 | 2.3 | GO:0030057 | desmosome(GO:0030057) |
| 0.1 | 6.5 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.1 | 0.7 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
| 0.1 | 1.4 | GO:0070938 | contractile ring(GO:0070938) |
| 0.1 | 1.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.1 | 1.7 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.1 | 5.0 | GO:0005902 | microvillus(GO:0005902) |
| 0.1 | 1.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.1 | 2.6 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.1 | 8.0 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.1 | 0.7 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.1 | 2.8 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.1 | 1.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.1 | 25.2 | GO:0005769 | early endosome(GO:0005769) |
| 0.1 | 3.9 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.1 | 0.9 | GO:0032039 | integrator complex(GO:0032039) |
| 0.1 | 0.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.1 | 7.1 | GO:0016605 | PML body(GO:0016605) |
| 0.1 | 12.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 1.6 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.0 | 8.3 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
| 0.0 | 1.0 | GO:0031985 | Golgi cisterna(GO:0031985) |
| 0.0 | 0.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.0 | 0.6 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.0 | 12.8 | GO:0001726 | ruffle(GO:0001726) |
| 0.0 | 0.5 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.0 | 0.6 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.0 | 2.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.0 | 4.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.0 | 84.1 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 0.9 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.0 | 0.7 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.0 | 0.6 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.0 | 2.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.0 | 3.7 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.0 | 8.6 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.0 | 0.8 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 5.4 | GO:0010008 | endosome membrane(GO:0010008) |
| 0.0 | 1.4 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.0 | 0.7 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.0 | 3.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.0 | 0.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
| 0.0 | 1.1 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.0 | 0.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.0 | 0.7 | GO:0046930 | pore complex(GO:0046930) |
| 0.0 | 11.4 | GO:0000790 | nuclear chromatin(GO:0000790) |
| 0.0 | 13.9 | GO:0031410 | cytoplasmic vesicle(GO:0031410) |
| 0.0 | 14.5 | GO:0005813 | centrosome(GO:0005813) |
| 0.0 | 3.1 | GO:0030667 | secretory granule membrane(GO:0030667) |
| 0.0 | 0.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.0 | 17.7 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.0 | 0.8 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 0.1 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 0.0 | 12.9 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
| 0.0 | 1.2 | GO:1990391 | DNA repair complex(GO:1990391) |
| 0.0 | 7.2 | GO:0016604 | nuclear body(GO:0016604) |
| 0.0 | 0.1 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.0 | 0.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.0 | 0.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.0 | 6.5 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.0 | 2.3 | GO:0005635 | nuclear envelope(GO:0005635) |
| 0.0 | 75.0 | GO:0005654 | nucleoplasm(GO:0005654) |
| 0.0 | 0.9 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.0 | 0.1 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.0 | 2.7 | GO:0005794 | Golgi apparatus(GO:0005794) |
| 0.0 | 78.1 | GO:0016021 | integral component of membrane(GO:0016021) |
| 0.0 | 1.1 | GO:0005667 | transcription factor complex(GO:0005667) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 10.7 | 171.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 8.1 | 24.2 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
| 7.4 | 22.2 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 7.2 | 36.1 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) |
| 6.2 | 18.6 | GO:0042007 | interleukin-18 binding(GO:0042007) |
| 6.2 | 24.7 | GO:0046979 | TAP2 binding(GO:0046979) |
| 5.2 | 26.0 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 4.2 | 12.7 | GO:0005139 | interleukin-7 receptor binding(GO:0005139) |
| 4.1 | 12.4 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) peroxidase inhibitor activity(GO:0036479) |
| 3.2 | 22.3 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 3.0 | 15.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 3.0 | 14.8 | GO:0048030 | disaccharide binding(GO:0048030) |
| 2.5 | 10.0 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 2.3 | 7.0 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
| 2.3 | 11.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 2.3 | 16.1 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
| 2.2 | 6.6 | GO:0042008 | interleukin-18 receptor activity(GO:0042008) |
| 2.1 | 8.2 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
| 2.1 | 47.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 2.1 | 6.2 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
| 1.9 | 18.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 1.8 | 5.4 | GO:0033862 | UMP kinase activity(GO:0033862) |
| 1.7 | 11.9 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 1.7 | 18.7 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 1.7 | 13.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 1.6 | 50.5 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 1.6 | 49.9 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
| 1.5 | 12.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
| 1.5 | 14.7 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 1.5 | 11.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 1.4 | 2.8 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 1.4 | 10.8 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 1.3 | 6.5 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 1.3 | 10.3 | GO:0031996 | thioesterase binding(GO:0031996) |
| 1.2 | 16.6 | GO:0031386 | protein tag(GO:0031386) |
| 1.2 | 21.2 | GO:0019864 | IgG binding(GO:0019864) |
| 1.2 | 10.5 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 1.0 | 8.3 | GO:0019863 | IgE binding(GO:0019863) |
| 1.0 | 4.1 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 1.0 | 38.2 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 1.0 | 2.9 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.9 | 4.7 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 0.9 | 20.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.9 | 45.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.9 | 46.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.9 | 5.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.8 | 3.4 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.8 | 3.0 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.7 | 30.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.7 | 3.7 | GO:0004556 | alpha-amylase activity(GO:0004556) |
| 0.7 | 6.5 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.7 | 6.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.7 | 2.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 0.7 | 6.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.7 | 0.7 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
| 0.6 | 2.4 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.6 | 3.6 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.6 | 8.2 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.6 | 23.8 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
| 0.6 | 1.7 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) cholestenol delta-isomerase activity(GO:0047750) |
| 0.6 | 1.7 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 0.5 | 4.2 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.5 | 13.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.5 | 3.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.5 | 2.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.5 | 6.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.5 | 1.8 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.5 | 6.8 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.4 | 9.9 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.4 | 3.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 0.4 | 7.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.4 | 8.9 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.4 | 7.9 | GO:0032183 | SUMO binding(GO:0032183) |
| 0.4 | 13.0 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.4 | 3.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.4 | 13.4 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
| 0.4 | 5.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.4 | 13.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.4 | 1.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.4 | 3.7 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.4 | 1.1 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.4 | 12.5 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.4 | 1.8 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.4 | 10.6 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.4 | 3.9 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.3 | 15.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.3 | 2.0 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
| 0.3 | 11.9 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.3 | 13.4 | GO:0043394 | proteoglycan binding(GO:0043394) |
| 0.3 | 9.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.3 | 1.2 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.3 | 1.8 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.3 | 3.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.3 | 1.2 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
| 0.3 | 18.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.3 | 1.2 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 0.3 | 1.1 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.3 | 4.7 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.3 | 8.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.3 | 1.9 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 0.3 | 0.8 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
| 0.3 | 1.6 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.3 | 34.8 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.3 | 1.8 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.3 | 38.9 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.2 | 2.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.2 | 3.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.2 | 9.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.2 | 6.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.2 | 0.7 | GO:0005368 | taurine transmembrane transporter activity(GO:0005368) taurine:sodium symporter activity(GO:0005369) |
| 0.2 | 1.8 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.2 | 2.0 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.2 | 2.4 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.2 | 0.6 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
| 0.2 | 1.5 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.2 | 4.8 | GO:0005522 | profilin binding(GO:0005522) |
| 0.2 | 0.8 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.2 | 3.0 | GO:0046790 | virion binding(GO:0046790) |
| 0.2 | 4.7 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
| 0.2 | 5.9 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.2 | 0.8 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.2 | 2.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.2 | 4.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.2 | 3.0 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.2 | 15.1 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.2 | 7.8 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.2 | 1.4 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 0.2 | 10.5 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.2 | 8.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.2 | 3.2 | GO:1990380 | Lys63-specific deubiquitinase activity(GO:0061578) Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.2 | 4.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.2 | 1.0 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
| 0.2 | 4.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.2 | 2.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.2 | 0.5 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
| 0.1 | 86.3 | GO:0005525 | GTP binding(GO:0005525) |
| 0.1 | 1.8 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.1 | 3.0 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
| 0.1 | 0.6 | GO:0034584 | piRNA binding(GO:0034584) |
| 0.1 | 0.9 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.1 | 0.7 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.1 | 14.8 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
| 0.1 | 0.9 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.1 | 2.9 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.1 | 1.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 4.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.1 | 0.4 | GO:0008441 | 3'(2'),5'-bisphosphate nucleotidase activity(GO:0008441) |
| 0.1 | 0.7 | GO:0001093 | TFIIB-class transcription factor binding(GO:0001093) |
| 0.1 | 1.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.1 | 0.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.1 | 0.7 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 0.1 | 2.3 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
| 0.1 | 5.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.1 | 3.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.1 | 5.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.1 | 1.7 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.1 | 1.0 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.1 | 3.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.1 | 2.7 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.1 | 0.7 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.1 | 2.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.1 | 3.0 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.1 | 1.0 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.1 | 18.0 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.1 | 1.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.1 | 20.3 | GO:0001047 | core promoter binding(GO:0001047) |
| 0.1 | 10.1 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
| 0.1 | 22.7 | GO:0004386 | helicase activity(GO:0004386) |
| 0.1 | 1.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.1 | 5.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.1 | 4.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.1 | 5.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.1 | 1.7 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.1 | 12.2 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
| 0.1 | 4.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.1 | 1.6 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.1 | 1.8 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.1 | 0.9 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.1 | 15.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.1 | 1.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.1 | 7.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 0.3 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.1 | 16.0 | GO:0005178 | integrin binding(GO:0005178) |
| 0.1 | 0.3 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 0.1 | 1.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 0.1 | 0.3 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.1 | 0.6 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.1 | 16.2 | GO:0003823 | antigen binding(GO:0003823) |
| 0.1 | 0.6 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.1 | 0.8 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.1 | 0.8 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.1 | 2.4 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.1 | 3.3 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.1 | 2.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.1 | 1.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.1 | 0.5 | GO:0070513 | death domain binding(GO:0070513) |
| 0.1 | 3.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.1 | 1.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.1 | 2.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.1 | 0.9 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.1 | 5.1 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.1 | 3.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.1 | 1.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.1 | 3.9 | GO:0042393 | histone binding(GO:0042393) |
| 0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.1 | 0.7 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.1 | 21.4 | GO:0030246 | carbohydrate binding(GO:0030246) |
| 0.1 | 0.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.1 | 0.5 | GO:0004372 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 0.1 | 1.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.1 | 16.9 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.0 | 1.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.0 | 0.2 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.0 | 0.1 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.0 | 2.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.0 | 0.8 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.0 | 0.3 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.0 | 1.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.0 | 0.4 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.0 | 0.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.0 | 1.7 | GO:0033558 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
| 0.0 | 23.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.0 | 0.4 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.0 | 2.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.0 | 3.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.0 | 0.9 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.0 | 1.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.0 | 3.5 | GO:0002039 | p53 binding(GO:0002039) |
| 0.0 | 0.2 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 0.0 | 1.4 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.0 | 0.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.0 | 1.6 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.0 | 0.7 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
| 0.0 | 0.2 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.0 | 0.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.0 | 3.3 | GO:0003682 | chromatin binding(GO:0003682) |
| 0.0 | 0.7 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.0 | 5.9 | GO:0005319 | lipid transporter activity(GO:0005319) |
| 0.0 | 0.8 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.0 | 2.1 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
| 0.0 | 1.3 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.0 | 1.4 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.0 | 0.1 | GO:0051500 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.0 | 1.9 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
| 0.0 | 0.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.0 | 1.6 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
| 0.0 | 0.1 | GO:0008650 | rRNA (uridine-2'-O-)-methyltransferase activity(GO:0008650) rRNA (uridine) methyltransferase activity(GO:0016436) |
| 0.0 | 0.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.0 | 0.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.0 | 0.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.0 | 0.5 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.0 | 8.0 | GO:0003712 | transcription cofactor activity(GO:0003712) |
| 0.0 | 1.0 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.0 | 0.7 | GO:0046961 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.0 | 3.4 | GO:0019838 | growth factor binding(GO:0019838) |
| 0.0 | 0.0 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.0 | 1.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.0 | 0.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.0 | 11.5 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
| 0.0 | 2.6 | GO:0005254 | chloride channel activity(GO:0005254) |
| 0.0 | 1.5 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.0 | 0.5 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.0 | 0.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.0 | 1.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.0 | 1.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.0 | 0.1 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.0 | 0.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.0 | 1.7 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
| 0.0 | 0.3 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.0 | 0.4 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.0 | 2.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.0 | 9.6 | GO:0008270 | zinc ion binding(GO:0008270) |
| 0.0 | 0.5 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.0 | 22.4 | GO:0003677 | DNA binding(GO:0003677) |
| 0.0 | 0.3 | GO:0015026 | coreceptor activity(GO:0015026) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.0 | 65.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.7 | 16.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.6 | 74.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.6 | 20.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.5 | 51.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.4 | 24.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.4 | 33.0 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.3 | 8.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.3 | 5.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.3 | 2.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.3 | 10.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.3 | 15.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.3 | 21.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.3 | 2.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.3 | 3.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.2 | 8.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.2 | 14.0 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.2 | 8.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.2 | 5.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.2 | 60.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.2 | 5.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.2 | 16.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.2 | 42.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.2 | 1.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.2 | 11.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 4.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.1 | 0.7 | ST ADRENERGIC | Adrenergic Pathway |
| 0.1 | 1.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.1 | 11.7 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.1 | 1.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.1 | 14.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.1 | 11.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.1 | 6.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.1 | 13.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.1 | 1.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.1 | 10.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.1 | 1.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.1 | 1.8 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.1 | 6.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.1 | 2.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.1 | 5.7 | PID SHP2 PATHWAY | SHP2 signaling |
| 0.1 | 4.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.1 | 1.7 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.1 | 8.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.1 | 3.8 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.1 | 8.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.1 | 0.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.1 | 1.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.1 | 2.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.1 | 2.5 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.1 | 25.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 24.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.1 | 6.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.1 | 0.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 2.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 2.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.0 | 1.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 0.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.0 | 2.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 0.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.0 | 1.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.0 | 2.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 0.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.0 | 1.3 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.0 | 1.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.0 | 0.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.0 | 0.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.0 | 1.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.0 | 0.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.2 | 370.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 3.2 | 34.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 1.9 | 68.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 1.7 | 34.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 1.7 | 19.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 1.7 | 40.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 1.2 | 80.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.9 | 31.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.8 | 76.3 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
| 0.7 | 56.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.6 | 21.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.6 | 10.4 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 0.6 | 6.4 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
| 0.5 | 43.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.5 | 10.6 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.5 | 15.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.5 | 12.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.4 | 10.0 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.4 | 5.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.4 | 17.7 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.4 | 3.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 0.4 | 5.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.3 | 6.8 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.3 | 30.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.3 | 11.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.3 | 3.9 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.3 | 4.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.3 | 8.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.2 | 0.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.2 | 8.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.2 | 4.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.2 | 2.8 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.2 | 10.0 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.2 | 3.4 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.2 | 1.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.2 | 14.4 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.2 | 12.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.2 | 0.7 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 0.2 | 10.3 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
| 0.1 | 2.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.1 | 1.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.1 | 1.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.1 | 11.5 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.1 | 4.9 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.1 | 13.8 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.1 | 9.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.1 | 3.9 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 0.1 | 2.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.1 | 5.0 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.1 | 1.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.1 | 1.7 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
| 0.1 | 3.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.1 | 8.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.1 | 3.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.1 | 1.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.1 | 1.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.1 | 3.0 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
| 0.1 | 2.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.1 | 1.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.1 | 1.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.1 | 3.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.1 | 4.5 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
| 0.1 | 5.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.0 | 14.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 0.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.0 | 1.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.0 | 1.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.0 | 1.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.0 | 5.0 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 4.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.0 | 0.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.0 | 0.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.0 | 2.9 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
| 0.0 | 1.0 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.0 | 0.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.0 | 1.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.0 | 3.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.0 | 7.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.0 | 0.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.0 | 1.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.0 | 3.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.0 | 0.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.0 | 0.9 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.0 | 0.7 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.0 | 1.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.0 | 2.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.0 | 2.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.0 | 0.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.0 | 0.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.0 | 1.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.0 | 1.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.0 | 1.1 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
| 0.0 | 0.2 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.0 | 0.4 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |